Despite the potential benefits of weight loss intervention programs, Peter Salgo, MD, and panelists Maria Lopes, MD, MS; Kari Uusinarkaus, MD, FAAFP, FNLA; Jeffrey D. Dunn, PharmD, MBA; and Yehuda Handelsman, MD, FACP, FACE, FNLA, explain that many barriers affect the outcomes of these programs.
Dr Salgo emphasizes that weight reduction is a crucial part of diabetes care; lifestyle modifications such as losing weight, making dietary changes, and increasing physical activity level are recommended for patients with diabetes. However, Dr Salgo explains that adherence to lifestyle modifications is challenging for many patients.
Dr Lopes agrees that lifestyle modification and wellness programs work; however, they are successful in only a minority of patients. Dr Uusinarkaus adds that healthcare professionals need to select the right patients for the right programs; ultimately, patients need to be inspired to be responsible for their own health.
Drs Handelsman and Dunn discuss the high costs associated with weight loss intervention programs, and consider what parties should be responsible for program expenses.
Together, the panelists conclude that a stronger governmental and societal approach can help combat the obesity epidemic.
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen